Published in Ann Rheum Dis on September 01, 1999
Socioeconomic status and the risk of developing rheumatoid arthritis: results from the Swedish EIRA study. Ann Rheum Dis (2005) 1.96
Disease activity and health status in rheumatoid arthritis: a case-control comparison between Norway and Lithuania. Ann Rheum Dis (2003) 1.58
Socioeconomic determinants of disability and depression in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken) (2011) 1.26
Socioeconomic deprivation and rheumatoid disease: what lessons for the health service? ERAS Study Group. Early Rheumatoid Arthritis Study. Ann Rheum Dis (2000) 1.08
Association of functional outcome with both personal- and area-level socioeconomic inequalities in patients with inflammatory polyarthritis. Arthritis Rheum (2009) 1.02
Socioeconomic disparities in pain: the role of economic hardship and daily financial worry. Health Psychol (2011) 0.94
Association between socioeconomic status, learned helplessness, and disease outcome in patients with inflammatory polyarthritis. Arthritis Care Res (Hoboken) (2012) 0.91
Arthritis, occupational class, and the aging US workforce. Am J Public Health (2011) 0.88
A novel measure of socioeconomic status using individual housing data to assess the association of SES with rheumatoid arthritis and its mortality: a population-based case-control study. BMJ Open (2015) 0.85
Comparative study of intramuscular gold and methotrexate in a rheumatoid arthritis population from a socially deprived area. Ann Rheum Dis (2001) 0.83
Impact of managed care health insurance system for indigent patients with rheumatoid arthritis in Puerto Rico. Clin Rheumatol (2013) 0.75
Measurement of patient outcome in arthritis. Arthritis Rheum (1980) 21.31
Social deprivation and premature mortality: regional comparison across England. BMJ (1993) 9.74
Deprivation and mortality in Scotland, 1981 and 1991. BMJ (1994) 8.68
Higher mortality in deprived areas: community or personal disadvantage? BMJ (1994) 7.69
Lifetime socioeconomic position and mortality: prospective observational study. BMJ (1997) 7.19
The mortality of rheumatoid arthritis. Arthritis Rheum (1994) 6.18
Cross sectional analysis of mortality by country of birth in England and Wales, 1970-92. BMJ (1997) 4.89
Deprivation and mortality in Glasgow: changes from 1980 to 1992. BMJ (1994) 4.17
Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden. J Rheumatol (1997) 3.65
Smoking and risk of rheumatoid arthritis. J Rheumatol (1993) 3.63
The epidemiology of rheumatoid arthritis in Rochester, Minnesota: a study of incidence, prevalence, and mortality. Am J Epidemiol (1980) 3.19
Counting the cost of social disadvantage in primary care: retrospective analysis of patient data. BMJ (1997) 2.82
Do the poor cost more? A multihospital study of patients' socioeconomic status and use of hospital resources. N Engl J Med (1990) 2.56
Survival, prognosis, and causes of death in rheumatoid arthritis. Arthritis Rheum (1986) 2.55
Cause of death in rheumatoid arthritis. Br J Rheumatol (1984) 2.12
Ten year mortality and causes of death in patients with rheumatoid arthritis. Br Med J (Clin Res Ed) (1985) 2.10
Most chronic diseases are reported more frequently by individuals with fewer than 12 years of formal education in the age 18-64 United States population. J Chronic Dis (1987) 2.06
Cardiovascular mortality in women with rheumatoid arthritis. J Rheumatol (1995) 1.96
Survival and cause of death in rheumatoid arthritis: a 25-year prospective followup. J Rheumatol (1984) 1.75
Death attributed to antirheumatic medication in a nationwide series of 1666 patients with rheumatoid arthritis who have died. J Rheumatol (1995) 1.66
Is rheumatoid arthritis becoming less severe? J Chronic Dis (1983) 1.64
Privilege and health--what is the connection? N Engl J Med (1993) 1.59
Formal education level as a significant marker of clinical status in rheumatoid arthritis. Arthritis Rheum (1988) 1.58
Cause and age at death in a prospective study of 100 patients with rheumatoid arthritis. Ann Rheum Dis (1981) 1.55
Mortality from cancer in patients with rheumatoid arthritis. Scand J Rheumatol (1995) 1.37
Mortality predictors among 263 patients with rheumatoid arthritis. J Rheumatol (1991) 1.35
Sociodemographic factors and the outcome of rheumatoid arthritis in young women. Ann Rheum Dis (1994) 1.33
Effect of social deprivation on disease severity and outcome in patients with rheumatoid arthritis. Ann Rheum Dis (1997) 1.13
Deprivation and health. Chadwick Lecture 1996. J R Coll Physicians Lond (1997) 1.02
The natural history of rheumatoid arthritis: a fifteen year follow-up study. The prognostic significance of features noted in the first year. Clin Rheumatol (1984) 1.01
Cardiovascular mortality in rheumatoid arthritis: how harmful are corticosteroids? J Rheumatol (1997) 1.00
Rheumatology function tests: grip strength, walking time, button test and questionnaires document and predict longterm morbidity and mortality in rheumatoid arthritis. J Rheumatol (1992) 0.96
Education, self-care, and outcomes of rheumatic diseases: further challenges to the "biomedical model" paradigm. Arthritis Care Res (1997) 0.91
Intention-to-treat analysis of 200 patients with rheumatoid arthritis 12 years after random allocation to either sulfasalazine or penicillamine. J Rheumatol (1998) 0.90
Remodeling the pyramid or remodeling the paradigms concerning rheumatoid arthritis--lessons from Hodgkin's disease and coronary artery disease. J Rheumatol (1990) 0.87
Is rheumatoid arthritis becoming a milder disease? Or are we starting second-line therapy in patients with milder disease? Br J Rheumatol (1996) 0.81
Gap between death rates of rich and poor widens. BMJ (1997) 0.78
Course and prognosis of early rheumatoid arthritis. Scand J Rheumatol Suppl (1989) 0.77
How to ensure that guidelines are effective. BMJ (1995) 4.31
Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate. Br Med J (Clin Res Ed) (1983) 2.63
Enteroscopic diagnosis of small bowel ulceration in patients receiving non-steroidal anti-inflammatory drugs. Lancet (1991) 2.37
Serum interleukin 6 levels in rheumatoid arthritis: correlations with clinical and laboratory indices of disease activity. Ann Rheum Dis (1993) 2.05
External fixation versus conservative treatment for distal radial fractures in adults. Cochrane Database Syst Rev (2007) 2.03
Cutting waiting lists. BMJ (1991) 2.02
Illiteracy in rheumatoid arthritis patients as determined by the Rapid Estimate of Adult Literacy in Medicine (REALM) score. Rheumatology (Oxford) (2002) 2.00
Effect of disease modifying agents on the lipid profiles of patients with rheumatoid arthritis. Ann Rheum Dis (1997) 1.87
Percutaneous pinning for treating distal radial fractures in adults. Cochrane Database Syst Rev (2007) 1.82
Does second-line therapy affect the radiological progression of rheumatoid arthritis? Ann Rheum Dis (1984) 1.69
Lack of radiological and clinical benefit over two years of low dose prednisolone for rheumatoid arthritis: results of a randomised controlled trial. Ann Rheum Dis (2004) 1.69
Impaired cell mediated immunity in haemophilia in the absence of infection with human immunodeficiency virus. Br Med J (Clin Res Ed) (1986) 1.64
DNA mismatch binding defects, DNA damage tolerance, and mutator phenotypes in human colorectal carcinoma cell lines. Cancer Res (1995) 1.64
Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis. Rheumatology (Oxford) (2001) 1.63
Nonsteroidal peptic damage in rheumatoid patients receiving second-line drugs. Am J Gastroenterol (1991) 1.57
Surgical interventions for treating distal radial fractures in adults. Cochrane Database Syst Rev (2003) 1.57
Sulphasalazine for rheumatoid arthritis: toxicity in 774 patients monitored for one to 11 years. Br Med J (Clin Res Ed) (1986) 1.55
Misoprostol in patients taking non-steroidal anti-inflammatory drugs. BMJ (1995) 1.54
Which component of sulphasalazine is active in rheumatoid arthritis? Br Med J (Clin Res Ed) (1985) 1.51
A rheumatological dilemma: is it possible to modify the course of rheumatoid arthritis? Can we answer the question? Ann Rheum Dis (1985) 1.50
Thiopurine methyltransferase genotype predicts therapy-limiting severe toxicity from azathioprine. Ann Intern Med (1998) 1.50
Effect of acetylator phenotype on efficacy and toxicity of sulphasalazine in rheumatoid arthritis. Ann Rheum Dis (1985) 1.49
Alteration of thiol and superoxide dismutase status in rheumatoid arthritis treated with sulphasalazine. Br J Rheumatol (1987) 1.45
Surgical interventions for treating distal radial fractures in adults. Cochrane Database Syst Rev (2001) 1.44
Small bowel ulceration in patients receiving non-steroidal anti-inflammatory drugs for rheumatoid arthritis. Q J Med (1986) 1.44
Antineutrophil cytoplasmic antibody titres in patients with recent infection. Br J Rheumatol (1993) 1.42
The 'natural' history of active rheumatoid arthritis over 3-6 months--an analysis of patients enrolled into trials of potential disease-modifying anti-rheumatic drugs, and treated with placebo. Br J Rheumatol (1993) 1.42
A case of orbital myositis associated with rheumatoid arthritis. Ann Rheum Dis (2002) 1.40
Pneumocystis carinii infection complicating cytotoxic therapy in two patients with lymphopenia, but a normal total white cell count. Br J Rheumatol (1992) 1.39
Availability of condoms in district general hospitals. BMJ (1990) 1.39
Predictive value of interleukin 1 gene polymorphisms for surgery. Ann Rheum Dis (2000) 1.38
The use of the Internet as a resource for health information among patients attending a rheumatology clinic. Rheumatology (Oxford) (2002) 1.33
Co-ordinated multidisciplinary approaches for inpatient rehabilitation of older patients with proximal femoral fractures. Cochrane Database Syst Rev (2001) 1.33
Sulphasalazine: a 'new' antirheumatic drug. Br J Rheumatol (1984) 1.30
Interventions for treating proximal humeral fractures in adults. Cochrane Database Syst Rev (2003) 1.30
Sulphasalazine in the treatment of rheumatoid arthritis: relationship of dose and serum levels to efficacy. Br J Rheumatol (1985) 1.30
Effect of sulphasalazine on the radiological progression of rheumatoid arthritis. Ann Rheum Dis (1987) 1.29
Hedgehog signalling is required for maintenance of myf5 and myoD expression and timely terminal differentiation in zebrafish adaxial myogenesis. Dev Biol (2001) 1.28
Erythrocytosis secondary to increased oxygen affinity of a mutant hemoglobin, hemoglobin Kempsey. Blood (1968) 1.26
Triple therapy in early active rheumatoid arthritis: a randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies. Arthritis Rheum (2008) 1.24
HTLV-III seropositivity in European haemophiliacs exposed to Factor VIII concentrate imported from the USA. Lancet (1984) 1.20
A double blind, randomised, multicentre comparison of two doses of intravenous iloprost in the treatment of Raynaud's phenomenon secondary to connective tissue diseases. Ann Rheum Dis (1991) 1.20
Clinical and laboratory studies of levamisole in patients with rheumatoid arthritis. Q J Med (1978) 1.19
Geriatric rehabilitation following fractures in older people: a systematic review. Health Technol Assess (2000) 1.18
Identification of human herpesvirus 6-specific DNA sequences in two patients with non-Hodgkin's lymphoma. Leukemia (1988) 1.18
Effects of altering dietary essential fatty acids on requirements for non-steroidal anti-inflammatory drugs in patients with rheumatoid arthritis: a double blind placebo controlled study. Ann Rheum Dis (1988) 1.16
Co-ordinated multidisciplinary approaches for inpatient rehabilitation of older patients with proximal femoral fractures. Cochrane Database Syst Rev (2000) 1.14
Continued use of non-steroidal anti-inflammatory drugs: an index of clinical efficacy. Br J Clin Pharmacol (1978) 1.14
Conservative interventions for treating distal radial fractures in adults. Cochrane Database Syst Rev (2003) 1.14
Effect of social deprivation on disease severity and outcome in patients with rheumatoid arthritis. Ann Rheum Dis (1997) 1.13
Immunological abnormalities in haemophilia: are they caused by American factor VIII concentrate? Br Med J (Clin Res Ed) (1983) 1.12
N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosourea sensitivity in mismatch repair-defective human cells. Cancer Res (1998) 1.11
Genomic instability and tolerance to alkylating agents. Cancer Surv (1996) 1.11
Improved functional outcome in patients with early rheumatoid arthritis treated with intramuscular gold: results of a five year prospective study. Ann Rheum Dis (1998) 1.10
Recurrent focal myositis. Rheumatology (Oxford) (1999) 1.10
Does the order of second-line treatment in rheumatoid arthritis matter? Br Med J (Clin Res Ed) (1982) 1.09
Downturn in hip fracture incidence. Public Health Rep (1996) 1.09
HIV-1 infection in haemophilia. Baillieres Clin Haematol (1990) 1.09
Social surveys in HIV/AIDS: telling or writing? A comparison of interview and postal methods. Health Educ Res (1992) 1.08
Gold induced aplastic anaemia unresponsive to G-CSF. Ann Rheum Dis (1993) 1.08
Second line (disease modifying) treatment in rheumatoid arthritis: which drug for which patient? Ann Rheum Dis (1993) 1.08
Outstanding issues in use of disease-modifying agents in rheumatoid arthritis. Lancet (1999) 1.07
The relationship of sulfoxidation status to efficacy and toxicity of penicillamine in the treatment of rheumatoid arthritis. Arthritis Rheum (1990) 1.07
Physeal fractures: Part 1. Epidemiology in Olmsted County, Minnesota, 1979-1988. J Pediatr Orthop (1994) 1.06
Uptake of breast screening by Asian women. J Public Health Med (1995) 1.04
Analysis of transforming growth factor beta1 gene polymorphisms in patients with systemic sclerosis. Ann Rheum Dis (2002) 1.03
Oral gold: a comparison with placebo and with intramuscular sodium aurothiomalate. Clin Rheumatol (1984) 1.03
Selection for beta 2-microglobulin mutation in mismatch repair-defective colorectal carcinomas. Curr Biol (1996) 1.03
Disease association of two distinct interleukin-18 promoter polymorphisms in Caucasian rheumatoid arthritis patients. Genes Immun (2005) 1.02
Rehabilitation for distal radial fractures in adults. Cochrane Database Syst Rev (2006) 1.01
Sex and the risk of HIV infection: the role of alcohol. Br J Addict (1992) 1.00
Pulmonary artery pressure variation in patients with connective tissue disease: 24 hour ambulatory pulmonary artery pressure monitoring. Thorax (1998) 1.00
Audit and research. Lancet (1992) 0.99
Different methods of external fixation for treating distal radial fractures in adults. Cochrane Database Syst Rev (2008) 0.99
Oral iloprost in Raynaud's phenomenon secondary to systemic sclerosis: a multicentre, placebo-controlled, dose-comparison study. Br J Rheumatol (1998) 0.98
Can treatment really influence the radiological progression of rheumatoid arthritis? Br J Rheumatol (1986) 0.97
Increased prostacyclin metabolites and decreased red cell deformability in patients with systemic sclerosis and Raynaud's syndrome. Prostaglandins Leukot Med (1985) 0.96
Anti-inflammatory analgesic drug responders and non-responders: a clinico-pharmacological study of flurbiprofen. Br J Clin Pharmacol (1977) 0.95
Anaesthesia for treating distal radial fracture in adults. Cochrane Database Syst Rev (2002) 0.94
Does sulphoxidation state predict gold toxicity in rheumatoid arthritis? Br Med J (Clin Res Ed) (1987) 0.94
Effects of hormone replacement therapy in rheumatoid arthritis: a double blind placebo-controlled study. Ann Rheum Dis (1994) 0.92
Degree and extent of response to sulphasalazine or penicillamine therapy for rheumatoid arthritis: results from a routine clinical environment over a two-year period. Q J Med (1990) 0.92
Comparison of white blood cell dyscrasias during sulphasalazine therapy of rheumatoid arthritis and inflammatory bowel disease. Drugs (1986) 0.92
A three year follow up of patients allocated to placebo, or oral or injectable gold therapy for rheumatoid arthritis. Ann Rheum Dis (1986) 0.92
Intention-to-treat analysis of 200 patients with rheumatoid arthritis 12 years after random allocation to either sulfasalazine or penicillamine. J Rheumatol (1998) 0.90
A pilot study of a Mediterranean-type diet intervention in female patients with rheumatoid arthritis living in areas of social deprivation in Glasgow. Ann Rheum Dis (2007) 0.90